この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. Aishat M.に依頼
United States
PhD Pharmacologist | Oncology Scientific Strategist | Medical Writer | Clinical Trial & Medical Affairs Communications |
プロフィール概要
専門分野
サービス
Writing
Medical Writing,
Technical Writing,
General Proofreading & Editing
Research
Scientific and Technical Research,
Systematic Literature Review
Consulting
Scientific and Technical Consulting
職務経験
Scientific Strategist
Onconarrative
1月 2026 - 現在
Scientific Communications Manager
Binaytara
2月 2025 - 現在
Grant Writer
HURO AI
9月 2024 - 11月 2024
Doctoral Research Scientist
Indiana University - Indianapolis
8月 2019 - 6月 2024
Undergraduate Research Assistant
Albany State University
9月 2015 - 5月 2019
Student Editor
Albany State University
9月 2015 - 5月 2019
学歴
PhD (Pharmacology)
Indiana University/Purdue University at Indianapolis - United States
8月 2019 - 6月 2024
Bachelor of Science (Biological Science)
Albany State University
8月 2015 - 5月 2019 ![]()
BSc. Biology
Albany State University - United States
1月 2015 - 5月 2019
認定資格
出版物
JOURNAL ARTICLE
Lakshmi Prabhu, Matthew Martin, Lan Chen, Özlem Demir, Jiamin Jin, Xiumei Huang, Aishat Motolani, Mengyao Sun, Guanglong Jiang, Harikrishna Nakshatri, et al. (2023). Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue . Genes & Diseases.
Han Wei, Antja-Voy Hartley, Aishat Motolani, Guanglong Jiang, Ahmad Safa, Lakshmi Prabhu, Yunlong Liu, Tao Lu(2022). A complex signature network that controls the upregulation of PRMT5 in colorectal cancer . Genes & Diseases. 9. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 285--287. Elsevier {BV}
PREPRINT
Anbukkarasi Muniyandi, Matthew Martin, Mengyao Sun, Kamakshi Sishtla, Nathan R Jensen, Aishat Motolani, Xiaoping Qi, Michael E Boulton, Lakshmi Prabhu, Tao Lu, et al.(2022). PRMT5 is a therapeutic target in choroidal neovascularization . Cold Spring Harbor Laboratory